BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
- Status
- TERMINATED
- Phase
- PHASE3
Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2